These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7646843)

  • 21. [Influence of ACE inhibitors and fibrates on endothelial function].
    Januszewicz A
    Kardiol Pol; 2005 Jun; 62 Suppl 2():II60-4. PubMed ID: 19813338
    [No Abstract]   [Full Text] [Related]  

  • 22. Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: contribution of the inhibitory action of angiotensin-converting enzyme.
    Hirota T; Ohki K; Kawagishi R; Kajimoto Y; Mizuno S; Nakamura Y; Kitakaze M
    Hypertens Res; 2007 Jun; 30(6):489-96. PubMed ID: 17664851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of protein-restricted diets on proteinuria and endothelial dysfunction.
    Ecder T
    J Ren Nutr; 2009 Sep; 19(5 Suppl):S13-4. PubMed ID: 19712868
    [No Abstract]   [Full Text] [Related]  

  • 24. What is the role of angiotensin-receptor blockade in cardiovascular protection?
    Cohn JN
    Am Heart J; 2006 Nov; 152(5):859.e1-8. PubMed ID: 17070145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Endothelial dysfunction in cardiovascular diseases: therapeutic implications after coronary angioplasty].
    Bauters C; Meurice T; Van Belle E; Lablanche JM; Bertrand ME
    Arch Mal Coeur Vaiss; 1997 Nov; 90 Spec No 6():35-9. PubMed ID: 9515112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Role of the endothelium in the control of vascular motility: physiologic aspects and physiopathologic implications in cardiovascular diseases].
    Limone P; Boeri E; Molinatti GM
    Minerva Med; 1993 Oct; 84(10):499-505. PubMed ID: 8247303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelial dysfunction and inhibition of converting enzyme.
    Vanhoutte PM
    Eur Heart J; 1998 Sep; 19 Suppl J():J7-15. PubMed ID: 9796835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Vascular endothelium--function, disorders and clinical modification probes].
    Leśniak W; Kolasińska-Kloch W; Kieć B
    Folia Med Cracov; 2001; 42(1-2):5-14. PubMed ID: 11712325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelial dysfunction: clinical strategies for treating oxidant stress.
    Fenster BE; Tsao PS; Rockson SG
    Am Heart J; 2003 Aug; 146(2):218-26. PubMed ID: 12891188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin-converting enzyme and vascular remodeling.
    Heeneman S; Sluimer JC; Daemen MJ
    Circ Res; 2007 Aug; 101(5):441-54. PubMed ID: 17761934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular health: the emerging appreciation of the endothelium.
    Talley JD
    J Ark Med Soc; 1997 Feb; 93(9):454-5. PubMed ID: 9046759
    [No Abstract]   [Full Text] [Related]  

  • 32. Endothelial dysfunction: its pathogenic role in atherosclerosis and its reversal by ACE inhibition.
    Neutel JM
    Postgrad Med; 2000 Oct; 108(5 Suppl):4-11. PubMed ID: 19667535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting endothelial dysfunction in hypertensive subjects.
    Thuillez C; Richard V
    J Hum Hypertens; 2005 Jun; 19 Suppl 1():S21-5. PubMed ID: 16075029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of angiotensin-converting enzyme inhibition on endothelial dysfunction: potential role in myocardial ischemia.
    Pepine CJ
    Am J Cardiol; 1998 Nov; 82(10A):23S-27S. PubMed ID: 9860352
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effects of inhibitors of the angiotensin-converting enzyme on endothelial dysfunction in patients with stable angina pectoris].
    Volkov VI; Abidova KR
    Lik Sprava; 2001; (3):62-5. PubMed ID: 11560030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvement of endothelium-derived hyperpolarizing factor function by renin-angiotensin system inhibition: paving the way towards prevention of age-related endothelial dysfunction.
    Roks AJ
    J Hypertens; 2002 Mar; 20(3):363-5. PubMed ID: 11875297
    [No Abstract]   [Full Text] [Related]  

  • 37. [Possibilities of ramipril in primary and secondary prevention of cardiovascular diseases].
    Tkacheva ON; Sharashkina NV
    Kardiologiia; 2010; 50(8):63-6. PubMed ID: 21105331
    [No Abstract]   [Full Text] [Related]  

  • 38. Anti-platelet function of human endothelial cells: augmentation by angiotensin-converting enzyme inhibitors?
    Orzechowski HD
    J Hypertens; 2003 Jul; 21(7):1259-61. PubMed ID: 12817169
    [No Abstract]   [Full Text] [Related]  

  • 39. Does antihypertensive therapy improve the function of the vascular endothelium?
    Miller VM
    Hypertension; 1990 Nov; 16(5):541-3. PubMed ID: 2228154
    [No Abstract]   [Full Text] [Related]  

  • 40. A critical look at cardiovascular translational research.
    Busse R; Fleming I
    Am J Physiol; 1999 Nov; 277(5):H1655-60. PubMed ID: 10564117
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.